全球动物疫苗市场按动物类型、技术、给药途径、分销管道和地区划分

2025 年全球兽用疫苗市场价值预估为 104.6 亿美元，预计到 2032 年将达到 177 亿美元，2025 年至 2032 年的复合年增长率为 7.8%。

图。

兽用疫苗是给动物施用的生物製药，以刺激免疫系统并提供对疾病的主动免疫。疫苗接种可以保护单一动物感染疾病，并间接形成保护整个群体的群体免疫。过去几十年来，随着宠物成为人们家庭中不可或缺的一部分，人们的动物保健意识不断增强，带动全球兽用疫苗市场迅速扩张。此外，政府也强制要求给牲畜和宠物接种疫苗。疫苗接种和重组基因技术的发展使製造商能够开发出针对多种通用感染疾病的有效疫苗。

市场动态：

全球兽医疫苗市场受到宠物拥有量增加、动物保健支出增加、政府对动物疾病控制的倡议、通用感染疾病风险增加以及畜牧业集约化等因素的推动。然而，疫苗生产成本高、法规严格以及一些地区缺乏必要的基础设施和专业知识，阻碍了市场的成长。输送系统、治疗方法和表位图谱的进步为兽医疫苗市场提供了机会。製药公司正在开发重组蛋白和抗毒素，以有效预防猪瘟、禽流感、狂犬病和牛结核病，这些疾病对动物和公众健康构成重大威胁。单剂量製剂和无针一体式註射器的推出旨在降低疫苗接种成本并提高便利性。

本研究的主要特点

• 本报告对全球动物疫苗市场进行了详细分析，并以 2024 年为基准年，展示了预测期（2025-2032 年）的市场规模和复合年增长率。
• 它还强调了各个领域的潜在收益成长机会，并说明了该市场的引人注目的投资提案矩阵。
• 它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。
• 全球动物疫苗市场的主要企业是根据公司亮点、产品系列、关键亮点、财务绩效和策略等参数进行的分析。
• 本报告的见解可以帮助负责人和企业经营团队就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
• 全球动物疫苗市场报告针对该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
• 相关人员将透过用于分析全球动物疫苗市场的各种策略矩阵更轻鬆地做出决策。

目录

第一章 调查目的与前提条件

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告描述
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map（COM）

第三章市场动态、法规与趋势分析

• 市场动态
  • 驱动程式
  • 限制因素
  • 机会
• 影响分析
• 市场趋势
• 最新动态
• 收购和合作场景
• 技术概述
• 监管情景
• PEST分析

第 4 章。

• 整体影响
• 对需求和供给的影响
• COVID-19 市场影响

5. 全球动物疫苗市场（依技术划分） (2020-2032)

• 灭活疫苗
• 类毒素疫苗
• 减毒活疫苗
• 次单位疫苗和 DNA 疫苗
• 重组疫苗

6. 全球动物疫苗市场按动物类型划分（2020-2032 年）

• 宠物
• 家畜

7. 全球动物疫苗市场依给药途径划分（2020-2032 年）

• 皮下注射
• 肌肉注射
• 鼻腔内
• 其他的

8. 全球动物疫苗市场依通路划分（2020-2032 年）

• 民众
• 私人的

9. 全球动物疫苗市场按地区划分（2020-2032 年）

• 北美洲
• 拉丁美洲
• 欧洲
• 亚太地区
• 中东
• 非洲

第十章 竞争格局

• Aratana Therapeutics, Inc.
• Regeneus Ltd.
• Morphogenesis, Inc.
• Karyopharm Therapeutics, Inc.
• Zoetis, Inc.
• Eli Lilly and Company
• Merck & Co., Inc.
• Boehringer Ingelheim GmbH

第 11 章 分析师观点

• 命运之轮
• 分析师观点
• Coherent Opportunity Map（COM）

第 12 章参考文献与调查方法

• 参考
• 调查方法

Global Veterinary Vaccines Market is estimated to be valued at USD 10.46 Bn in 2025 and is expected to reach USD 17.70 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.8% from 2025 to 2032.

Figure. Veterinary Vaccines Market Share (%), By Region 2025

Veterinary vaccines are biological preparations administered to animals in order to stimulate the immune system and provide active immunity against a disease. Vaccination protects individual animals from infectious diseases and generates herd immunity which indirectly protects the whole community. The global veterinary vaccine market has shown rapid expansion over the past few decades driven by the increasing awareness about animal healthcare as pets have become an integral part of people's families. Government mandates in various countries have also encouraged vaccination of livestock and companion animals. Advancements in vaccination technologies and recombinant procedures have enabled manufacturers to develop efficacious vaccines against a wide range of zoonotic diseases.

Market Dynamics:

The global veterinary vaccine market is driven by factors such as rising pet adoption, growing animal healthcare expenditure, government initiatives for animal disease control, increase in the risk of zoonotic diseases, and intensification of livestock farming. However, high cost of vaccine production, stringent regulations and lack of necessary infrastructure and expertise in some regions constrain market growth. Advancements in delivery systems, therapeutic approaches, and epitope mapping offer opportunities in the veterinary vaccines market. Pharmaceutical companies are developing recombinant protein and antitoxins for effective vaccination against swine fever, bird flu, rabies, and bovine tuberculosis which are major threats to animals as well as public health. Introduction of single-dose formulations and integrated needle-free injectors aim to reduce vaccination costs and improve convenience.

Key Features of the Study:

• This report provides an in-depth analysis of the global veterinary vaccines market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global veterinary vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study includes Aratana Therapeutics Inc., Regeneus Ltd., Morphogenesis Inc., Karyopharm Therapeutics Inc., Zoetis Inc., Eli Lilly and Company, Merck & Co. Inc., Boehringer Ingelheim GmbH., Elanco Animal Health, Virbac, Hester Biosciences Limited, Ceva Sante Animale, Phibro Animal Health Corporation, Kemin Industries, Inc., Finlab, Vaxxinova , Vira Vaccine Shaya, and VETERQUIMICA SA.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global veterinary vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global veterinary vaccines market.

Market Segmentation

• Technology:
  • Inactivated Vaccines
  • Toxoid Vaccines
  • Live Attenuated Vaccines
  • Subunit and DNA Vaccines
  • Recombinant Vaccines
• Animal Type:
  • Companion
  • Equine
  • Canine
  • Feline
  • Livestock
  • Bovine
  • Ovine
  • Porcine
  • Poultry
  • Others
• Route of Administration:
  • Subcutaneous Injection
  • Intramuscular Injection
  • Intranasal Administration
  • Others
• Distribution Channel
  • Public
  • Private
• Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Aratana Therapeutics Inc.
  • Regeneus Ltd.
  • Morphogenesis Inc.
  • Karyopharm Therapeutics Inc.
  • Zoetis Inc.
  • Eli Lilly and Company
  • Merck & Co. Inc.
  • Boehringer Ingelheim GmbH.
  • Elanco Animal Health
  • Virbac
  • Hester Biosciences Limited
  • Ceva Sante Animale
  • Phibro Animal Health Corporation
  • Kemin Industries, Inc.
  • Finlab
  • Vaxxinova
  • Vira Vaccine Shaya
  • VETERQUIMICA SA

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Technology
  • Market Snapshot, By Animal Type
  • Market Snapshot, By Route of Administration
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Recent Developments
• Acquisitions and Partnerships Scenario
• Technology Overview
• Regulatory Scenario
• PEST Analysis

4. Global Veterinary Vaccine Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Impact on Supply and Demand
• COVID-19 Impact on the Market

5. Global Veterinary Vaccine Market, By Technology, 2020 - 2032, (US$ Billion)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Inactivated Vaccines
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Toxoid Vaccine
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Live Attenuated Vaccines
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Subunit and DNA Vaccines
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Recombinant Vaccines
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

6. Global Veterinary Vaccine Market, By Animal Type, 2020 - 2032, (US$ Billion)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Companion
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Equine
  • Canine
  • Feline
• Livestock
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Bovine
  • Ovine
  • Porcine
  • Poultry
  • Others

7. Global Veterinary Vaccine Market, By Route of Administration, 2020 - 2032, (US$ Billion)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Subcutaneous Injection
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Intramuscular Injection
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Intranasal Administration
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

8. Global Veterinary Vaccine Market, By Distribution Channel, 2020 - 2032, (US$ Billion)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Public
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Private
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

9. Global Veterinary Vaccine Market, By Region, 2020 - 2032, (US$ Billion)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Regions, 2020-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
  • U.S.
  • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
  • GCC
  • Israel
  • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (US$ Billion)
  • North Africa
  • Central Africa
  • South Africa

10. Competitive Landscape

• Aratana Therapeutics, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Regeneus Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Morphogenesis, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Karyopharm Therapeutics, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Zoetis, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Eli Lilly and Company
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Merck & Co., Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Boehringer Ingelheim GmbH
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies

11. Analyst View

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

12. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact